Category
We’ve posted a new tip sheet and a new “How I did it” piece that may yield some story ideas…
Independent journalist Lola Butcher reports that debate about the government’s 340B Drug Pricing Program continues to build as the program expands. “Like…
•
Health journalists received a few lessons in economics during a discussion last week on some alarming drug trends – largely…
This spring, Gilead Sciences Inc. introduced Solvaldi, a drug that could cure the liver virus that causes hepatitis C. The…
•
Reporters curious about the financial relationship between physicians and pharmaceutical companies can use publicly available data as a starting point…
•
When The Cincinnati Enquirer set out to look at the societal costs of the deadly opioid crisis, reporter Lisa Bernard-Kuhn…
•
A new report from the Dartmouth Atlas Project documents the wide variations of use of drug therapies by Medicare patients…
•
Seven patients in Tennessee are sick after injections from a compounding pharmacy, health officials say. AHCJ has some presentations from a…
•
ProPublica’s Tracy Weber, Charles Ornstein and Jennifer LaFleur, in an analysis of Medicare prescription records, found that “some doctors and…
•
Despite concluding that a drug research lab’s violations “were so ‘egregious,’ and pervasive that studies conducted there between April 2005…